A porous molecularly imprinted nanofilm for selective and sensitive sensing of an anticancer drug ruxolitinib
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A porous molecularly imprinted nanofilm for selective and sensitive sensing of an anticancer drug ruxolitinib
Authors
Keywords
Ruxolitinib, Porous nanofilm, Molecularly imprinted polymer, Photopolymerization, Voltammetry, Drug analysis
Journal
ANALYTICA CHIMICA ACTA
Volume 1187, Issue -, Pages 339143
Publisher
Elsevier BV
Online
2021-10-11
DOI
10.1016/j.aca.2021.339143
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Use of the JAK Inhibitor Ruxolitinib in the Treatment of Hemophagocytic Lymphohistiocytosis
- (2021) Camille Keenan et al. Frontiers in Immunology
- Sensitive ‘two-steps’ competitive assay for gonadotropin-releasing hormone detection via SPR biosensing and polynorepinephrine-based molecularly imprinted polymer
- (2021) Francesca Torrini et al. ANALYTICA CHIMICA ACTA
- Electrochemical methods for the determination of antibiotic residues in milk: A critical review
- (2021) Lucas Vinícius de Faria et al. ANALYTICA CHIMICA ACTA
- A molecularly imprinted electrochemical sensor based on highly selective and an ultra-trace assay of anti-cancer drug axitinib in its dosage form and biological samples
- (2021) Ahmet Cetinkaya et al. TALANTA
- Functional Polymers Structures for (Bio)Sensing Application—A Review
- (2020) Kamila Spychalska et al. Polymers
- The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation
- (2020) F. La Rosée et al. LEUKEMIA
- Improved Achiral and Chiral HPLC-UV Analysis of Ruxolitinib in Two Different Drug Formulations
- (2020) Alessandro Di Michele et al. Separations
- Development and Validation of a Reverse-Phase High-Performance Liquid Chromatography with Fluorescence Detection (RP-HPLC-FL) Method to Quantify Ruxolitinib in Plasma Samples
- (2019) Bruno Charlier et al. ANALYTICAL LETTERS
- Soft and flexible material-based affinity sensors
- (2019) Lingyin Meng et al. BIOTECHNOLOGY ADVANCES
- Recent advances and future prospects in molecularly imprinted polymers-based electrochemical biosensors
- (2018) Rijun Gui et al. BIOSENSORS & BIOELECTRONICS
- Molecularly imprinted polymers as receptor mimics for selective cell recognition
- (2018) Jianming Pan et al. CHEMICAL SOCIETY REVIEWS
- Molecularly Imprinted Fluorescent Test Strip for Direct, Rapid, and Visual Dopamine Detection in Tiny Amount of Biofluid
- (2018) Jixiang Wang et al. Small
- Inflammation and myeloproliferative neoplasms
- (2017) Federico Lussana et al. JOURNAL OF AUTOIMMUNITY
- Imprinting Technology in Electrochemical Biomimetic Sensors
- (2017) Manuela Frasco et al. SENSORS
- Bioinspired design of a polymer-based biohybrid sensor interface
- (2017) Erdoğan Özgür et al. SENSORS AND ACTUATORS B-CHEMICAL
- Molecularly-imprinted polymer sensors: realising their potential
- (2016) Lokman Uzun et al. BIOSENSORS & BIOELECTRONICS
- Overcoming treatment challenges in myelofibrosis and polycythemia vera: the role of ruxolitinib
- (2016) Jeffrey C. Bryan et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Molecular imprinting science and technology: a survey of the literature for the years 2004-2011
- (2014) Michael J. Whitcombe et al. JOURNAL OF MOLECULAR RECOGNITION
- Simultaneous quantification of ruxolitinib and nilotinib in rat plasma by LC–MS/MS: Application to a pharmacokinetic study
- (2014) Sridhar Veeraraghavan et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Biosensors: sense and sensibility
- (2013) Anthony P. F. Turner CHEMICAL SOCIETY REVIEWS
- Efficacy, safety and survival with ruxolitinib in patients with myelofibrosis: results of a median 2-year follow-up of COMFORT-I
- (2013) S. Verstovsek et al. HAEMATOLOGICA
- Optimizing management of ruxolitinib in patients with myelofibrosis: the need for individualized dosing
- (2013) Ruben A Mesa et al. Journal of Hematology & Oncology
- Ruxolitinib: The First FDA Approved Therapy for the Treatment of Myelofibrosis
- (2012) J. Mascarenhas et al. CLINICAL CANCER RESEARCH
- A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis
- (2012) Srdan Verstovsek et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recent advances in molecular imprinting technology: current status, challenges and highlighted applications
- (2011) Lingxin Chen et al. CHEMICAL SOCIETY REVIEWS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started